This topic contains a solution. Click here to go to the answer

Author Question: The internal receiver of a cochlear bone conduction implant is implanted over the a. zygomatic ... (Read 69 times)

ghost!

  • Hero Member
  • *****
  • Posts: 560
The internal receiver of a cochlear bone conduction implant is implanted over the
 
  a. zygomatic bone.
  b. temporal bone.
  c. parotid gland.
  d. middle turbinate bone.

Question 2

Which type of anesthesia agent is contraindicated while placing a graft in the middle ear?
 
  a. Carbon dioxide
  b. Carbon monoxide
  c. Lidocaine and epinephrine
  d. Nitrous oxide



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

at

  • Sr. Member
  • ****
  • Posts: 359
Answer to Question 1

ANS: B
The internal receiver of a cochlear implant is sutured in position over the temporal bone behind the ear.

Answer to Question 2

ANS: D
Nitrous oxide can diffuse into cavities and may cause expansion of the middle ear. Nitrous oxide is to be discontinued before placing a graft in a middle ear to minimize pressure that could displace the graft.




ghost!

  • Member
  • Posts: 560
Reply 2 on: Jul 18, 2018
Great answer, keep it coming :)


parshano

  • Member
  • Posts: 333
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

According to animal studies, the typical American diet is damaging to the liver and may result in allergies, low energy, digestive problems, and a lack of ability to detoxify harmful substances.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...

For a complete list of videos, visit our video library